Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study

Life Sciences

Volumn 78, Issue 17, 2006, Pages 1940-1944

  Yang, Jian ^a   Hu, Li Fang ^a   Liu, Xing ^a   Zhou, Fang ^a   Ding, Jian Hua ^a   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ATP sensitive potassium channel; Extracellular dopamine; Extracellular glutamate; Iptakalim; Unilateral 6 OHDA lesioned rats

Indexed keywords

DOPAMINE; GLUTAMIC ACID; IPTAKALIM; NEUROTRANSMITTER; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR SPACE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; GLUTAMIC ACID; MALE; MICRODIALYSIS; OXIDOPAMINE; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 33644620804     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.08.001     Document Type: Article

References (22)

1. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends in Neurosciences 12 10 1989 366 375
2. 2 underlies glutamate-dependent inhibition of striatal dopamine release Proceedings of the National Academy of Sciences of the United States of America 100 20 2003 11729 11734
3. 2 Journal of Neuroscience 23 7 2003 2744 2750
4. L. Bianchi, F. Galeffi, J.P. Bolam, and L.D. Corte The effect of 6-hydroxydopamine lesions on the release of amino acids in direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis European Journal of Neuroscience 18 4 2003 856 868
5. J.L. Hudson, C.G. van Horne, I. Stromberg, S. Brock, J. Clayton, J. Masserano, B.J. Hoffer, and G.A. Gerhardt Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats Brain Research 626 1-2 1993 167 174
6. B. Liss, and J. Roeper Molecular physiology of neuronal K-ATP channels (review) Molecular Membrane Biology 18 2 2001 117 127
7. C. Matute, E. Alberdi, G. Ibarretxe, and M.V. Sanchez-Gomez Excitotoxicity in glial cells European Journal of Pharmacology 447 2-3 2002 239 246
8. R. Nass, D.M. Miller, and R.D. Blakely C. elegans: a novel pharmacogenetic model to study Parkinson's disease Parkinsonism & Related Disorders 7 3 2001 185 191
9. N. Patil, D.R. Cox, D. Bhat, M. Faham, R.M. Myers, and A.S. Peterson A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation Nature Genetics 11 2 1995 126 129
10. S.T. Rouse, M.J. Marino, S.R. Bradley, H. Awad, M. Wittmann, and P.J. Conn Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders Pharmacology & Therapeutics 88 3 2000 427 435 Review
11. + channel blocker (quinine) on the dopamine decrease induced by selective D3 agonist (7-OH-DPAT) in the rat striatum Nihon Shinkei Seishin Yakurigaku Zasshi 21 5 2001 145 156
12. T. Tanaka, M. Yoshida, H. Yokoo, K. Mizoguchi, and M. Tanaka The role of ATP-sensitive potassium channels in striatal dopamine release: an in vivo microdialysis study Pharmacology, Biochemistry and Behavior 52 4 1995 831 835
13. 2 interaction in models of Parkinson's Disease Parkinsonism & Related Disorders 10 5 2004 273 280
14. H. Wang Pharmacological characteristics of the novel antihypertensive drug iptakalim hydrochloride and its molecular mechanism Drug Development Research 58 1 2003 65 68
15. H. Wang, Y.L. Zhang, X.C. Tang, H.S. Feng, and G. Hu Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain Molecular Pharmacology 66 5 2004 1160 1168
16. S. Wang, L.F. Hu, Y. Yang, J.H. Ding, and G. Hu Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease Neuropharmacology 48 2005 984 992
17. Y. Yang, X. Liu, Y. Long, F. Wang, J.H. Ding, S.Y. Liu, Y.H. Sun, H.H. Yao, H. Wang, J. Wu, and G. Hu Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alteration in rats Journal of Neuroscience Research 80 3 2005 442 449
18. Y.L. Yang, C.H. Meng, J.H. Ding, H.R. He, K. Ellsworth, J. Wu, and G. Hu Iptakalim hydrochloride protects cells against neurotoxin-induced glutamate transporter dysfunction in in vitro and in vivo models Brain Research 1049 1 2005 80 88
19. + Chinese Journal of Clinical Pharmacology and Therapeutics 8 1 2003 1 5
20. Y. Zhang, and G. Hu Iptakalim enhances astrocytic glutamate uptake activity YaoXue XueBao 39 12 2004 980 983 (Chinese)
21. H. Zhang, and D. Sulzer Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors Journal of Neuroscience 23 33 2003 10585 10592
22. Y.L. Zhang, and H. Wang Effects of iptakalim hydrochloride on glutamate receptors and spontaneous synaptic activities in rat hippocampal neurons Chinese Journal of Clinical Pharmacology and Therapeutics 9 3 2004 130 135